Management of Unilateral Mastoid Opacification with Mixed Hearing Loss and Active Infection/Inflammation

Initial Management

The American Academy of Pediatrics recommends starting IV antibiotics immediately upon diagnosis, as this is the cornerstone of initial management for otomastoiditis 1
High-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component, maximum 4000 mg/day) is recommended, divided into 2-3 doses 1, 2
Address pain management aggressively with acetaminophen or ibuprofen, as pain control is critical and should be initiated immediately regardless of antibiotic therapy 1, 2, 3

Mastoidectomy is indicated for failure to improve after 48 hours of appropriate IV antibiotics, development of subperiosteal abscess, presence of cholesteatoma, intracranial complications, or clinical deterioration at any point 1, 4
Modified radical mastoidectomy is required when subperiosteal abscess is present or cholesteatoma is identified 4

If the patient fails initial amoxicillin-clavulanate therapy, consider switching to intramuscular ceftriaxone (50 mg/kg/day for 1-3 days, with 3-day course superior to 1-day) 2
Continue IV antibiotics for 7-10 days postoperatively if mastoidectomy is performed, then transition to oral antibiotics based on culture results 4

Perform age-appropriate hearing testing if middle ear effusion persists for ≥3 months after resolution of acute symptoms 1, 5, 6
Regular follow-up is essential to ensure complete resolution and monitor for potential complications or recurrence 1

Prior antibiotic treatment does not prevent mastoiditis development, as 33-81% of patients diagnosed with acute mastoiditis had received antibiotics before admission 1, 2
Do not delay imaging if clinical deterioration occurs, as no reliable clinical signs distinguish patients with coexistent intracranial complications 1
Antibiotics alone have only a 10% success rate for acute mastoiditis, making early consideration of surgical intervention important 1, 4